1.65
Neumora Therapeutics Inc Aktie (NMRA) Neueste Nachrichten
How volatile is Neumora Therapeutics Inc. stock compared to the marketUnprecedented market success - Jammu Links News
Why is Neumora Therapeutics Inc. stock attracting strong analyst attentionSignificant capital appreciation - Jammu Links News
Does Neumora Therapeutics Inc. stock perform well during market downturnsCapitalize on fast-growing stocks today - Jammu Links News
How does Neumora Therapeutics Inc. generate profit in a changing economyCapitalize on market trends with expert guidance - Jammu Links News
Is it the right time to buy Neumora Therapeutics Inc. stockFree Trading Psychology Coaching - Jammu Links News
What institutional investors are buying Neumora Therapeutics Inc. stockAchieve triple-digit returns with smart investing - Jammu Links News
What are the latest earnings results for Neumora Therapeutics Inc.Capitalize on market momentum for maximum profit - Jammu Links News
Neumora Therapeutics to Report Q2 2025 Financial Results on August 6, 2025 - AInvest
What are analysts’ price targets for Neumora Therapeutics Inc. in the next 12 monthsAI Powered Tips With High Returns - Jammu Links News
How strong is Neumora Therapeutics Inc. company’s balance sheetExpert Picks Entry Points For 2025 - Jammu Links News
Neumora Therapeutics (NMRA) Expected to Post Earnings on Wednesday - MarketBeat
What is the dividend policy of Neumora Therapeutics Inc. stockPost Market Planner That Work - Jammu Links News
How many analysts rate Neumora Therapeutics Inc. as a “Buy”Chart Pattern Updates For Fast Growth - Jammu Links News
What are the technical indicators suggesting about Neumora Therapeutics Inc.Chart Pattern Guidance To Watch Now - Jammu Links News
Key metrics from Neumora Therapeutics Inc.’s quarterly dataTrade Insight With Community Collaboration Supported - metal.it
What are Neumora Therapeutics Inc. company’s key revenue driversAI Powered Planner Backed By Experts - Jammu Links News
Why Neumora Therapeutics Inc. stock attracts strong analyst attentionStrong Buy With Technical Confidence Supported - beatles.ru
Published on: 2025-07-30 12:15:41 - metal.it
Mizuho Boosts Neumora Price Target to $5, Maintains Outperform Rating - AInvest
Pegasystems Delivers Strong Q2 Results, Raises Price Target to $58 - AInvest
Mizuho Raises Price Target for Neumora (NMRA), Keeps Outperform Rating - Insider Monkey
Published on: 2025-07-29 01:24:00 - metal.it
What is Neumora Therapeutics Inc. company’s growth strategyNavigate market volatility with smart strategies - jammulinksnews.com
When is Neumora Therapeutics Inc. stock expected to show significant growthCapitalize on market trends with expert guidance - Jammu Links News
Is Neumora Therapeutics Inc. a good long term investmentFree Investment Community - PrintWeekIndia
Neumora Therapeutics Inc. Stock Analysis and ForecastExponential wealth increase - PrintWeekIndia
What drives Neumora Therapeutics Inc. stock priceHigh-yield growth strategies - PrintWeekIndia
Is Neumora Therapeutics Inc. stock overhyped or has real potentialExceptional portfolio growth - jammulinksnews.com
Analysts Set Neumora Therapeutics, Inc. (NASDAQ:NMRA) PT at $7.14 - MarketBeat
Neumora Soared 24.33%—What Sparked This Volcanic Rally in a Biotech Underdog? - AInvest
Neumora Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 - The Manila Times
Neumora Therapeutics Announces Q2 2025 Financial Results, Business Update - AInvest
What analysts say about Neumora Therapeutics Inc. stockMarket-leading profit generation - Autocar Professional
Mizuho Lifts PT on Neumora Therapeutics (NMRA) to $5 from $4, Keeps Outperform Rating - MSN
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):